EC approves new meningitis vaccine
MenQuadfi® has been approved for use in individuals 12 months of age and older, based on its safety and immunogenicity in 6,300 trial subjects.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
